Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5937

1.

Epidemiology and risk factors for multidrug-resistant bacteria in critically ill patients with liver disease.

Choudhuri AH, Khurana P, Biswas PS, Uppal R.

Saudi J Anaesth. 2018 Jul-Sep;12(3):389-394. doi: 10.4103/sja.SJA_749_17.

PMID:
30100836
2.

Clinical Efficacy of Spectral Computed Tomography for Evaluating Liver Function in Patients with Budd-Chiari Syndrome.

Su L, Hu L, Liang P, Wu Y, Sun Q, Gao J.

Acad Radiol. 2018 Aug 9. pii: S1076-6332(18)30242-3. doi: 10.1016/j.acra.2018.05.003. [Epub ahead of print]

PMID:
30098862
3.

Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma.

Canale M, Ulivi P, Foschi FG, Scarpi E, De Matteis S, Donati G, Ercolani G, Scartozzi M, Faloppi L, Passardi A, Tamburini E, Valgiusti M, Marisi G, Frassineti GL, Casadei Gardini A.

Crit Rev Oncol Hematol. 2018 Sep;129:44-53. doi: 10.1016/j.critrevonc.2018.06.017. Epub 2018 Jun 23. Review.

PMID:
30097237
4.

Proposal for subclassification to select patients for hepatectomy with intermediate hepatocellular carcinoma and Child-Pugh A liver function: A double-center study from China.

Xu W, Rao Q, An Y, Li M, Xu G, Sang X, Lu X, Zhang Z, Mao Y.

Medicine (Baltimore). 2018 Aug;97(32):e11800. doi: 10.1097/MD.0000000000011800.

5.

Management of ruptured liver segment IV hepatocellular carcinoma: is transarterial embolization (TAE) superior to chemoembolization (TACE)?-the jury is still out.

Bakopoulos A, Koliakos N, Tsilimigras DI, Schizas D, Moris D, Angelopoulos A, Spanakos S, Spartalis E, Patapis P, Skandalakis P, Troupis T.

Ann Transl Med. 2018 Jul;6(13):272. doi: 10.21037/atm.2018.06.01.

6.

Clinical outcomes with long-term sorafenib treatment of patients with hepatocellular carcinoma: a multicenter real-life study.

Sacco R, Granito A, Bargellini I, Zolfino T, Saitta C, Marzi L, Tapete G, Bresci G, Marinelli S, Tovoli F, Attardo S, Rossi M, Urbani L, Marchi S, Buccianti P, Cabibbo G.

Future Oncol. 2018 Aug 9. doi: 10.2217/fon-2018-0281. [Epub ahead of print]

PMID:
30091371
7.

Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection in adults.

Nehra V, Rizza SA, Temesgen Z.

Drugs Today (Barc). 2018 Jul;54(7):407-421. doi: 10.1358/dot.2018.54.7.2828188.

PMID:
30090878
8.

Infectious endocarditis in the case of cirrhosis: where do we stand?

Allaire M, Ollivier-Hourmand I, Garioud A, Heng R, Dao T, Cadranel JD.

Eur J Gastroenterol Hepatol. 2018 Aug 6. doi: 10.1097/MEG.0000000000001211. [Epub ahead of print]

PMID:
30085963
9.

A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma.

Nakamura M, Fukumitsu N, Kamizawa S, Numajiri H, Nemoto Murofushi K, Ohnishi K, Aihara T, Ishikawa H, Okumura T, Tsuboi K, Sakurai H.

J Radiat Res. 2018 Aug 6. doi: 10.1093/jrr/rry056. [Epub ahead of print]

PMID:
30085200
10.

Accuracy of calprotectin using the Quantum Blue® Reader for the diagnosis of spontaneous bacterial peritonitis in liver cirrhosis.

Weil D, Heurgue-Berlot A, Monnet E, Chassagne S, Cervoni JP, Feron T, Jaeger T, Grandvallet C, Muel E, Bronowicki JP, Thiefin G, Di Martino V, Bardonnet K, Thévenot T.

Hepatol Res. 2018 Aug 7. doi: 10.1111/hepr.13239. [Epub ahead of print]

PMID:
30084186
11.

Re-examination using newly proposed diagnostic criteria of acute-on-chronic liver failure in Japan.

Nojiri S, Tsuchiya A, Terai S.

Hepatol Res. 2018 Aug 7. doi: 10.1111/hepr.13238. [Epub ahead of print] No abstract available.

PMID:
30084146
12.

Post-operative albumin-bilirubin grade predicts long-term outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection.

Amisaki M, Uchinaka E, Morimoto M, Tokuyasu N, Sakamoto T, Honjo S, Saito H, Fujiwara Y.

Hepatobiliary Pancreat Dis Int. 2018 Jul 26. pii: S1499-3872(18)30151-6. doi: 10.1016/j.hbpd.2018.07.011. [Epub ahead of print]

PMID:
30077606
13.

Palliative surgery for advanced gastric cancer: Partial gastrectomy using the inverted laparoscopic and endoscopic cooperative surgery method.

Takechi H, Fujikuni N, Takemoto Y, Tanabe K, Amano H, Noriyuki T, Nakahara M.

Int J Surg Case Rep. 2018 Jul 21;50:42-45. doi: 10.1016/j.ijscr.2018.06.042. [Epub ahead of print]

14.

Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis: A retrospective observational study.

Kotani K, Kawabe J, Higashiyama S, Yoshida A, Kawamura E, Tamori A, Shiomi S, Kawada N.

Medicine (Baltimore). 2018 Aug;97(31):e11765. doi: 10.1097/MD.0000000000011765.

15.

Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.

Yang B, Zheng B, Yang M, Zeng Z, Yang F, Pu J, Li C, Liao Z.

Hepatol Int. 2018 Aug 2. doi: 10.1007/s12072-018-9888-4. [Epub ahead of print] Review.

PMID:
30073454
16.

Gall bladder wall thickening as non-invasive screening parameter for esophageal varices - a comparative endoscopic - sonographic study.

Tsaknakis B, Masri R, Amanzada A, Petzold G, Ellenrieder V, Neesse A, Kunsch S.

BMC Gastroenterol. 2018 Aug 2;18(1):123. doi: 10.1186/s12876-018-0852-5.

17.

LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway.

Zhang Y, Mi L, Xuan Y, Gao C, Wang YH, Ming HX, Liu J.

Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4861-4868. doi: 10.26355/eurrev_201808_15622.

PMID:
30070317
18.

HINT: a novel prognostic model for patients with hepatitis B virus-related acute-on-chronic liver failure.

Wu D, Sun Z, Liu X, Rao Q, Chen W, Wang J, Xie Z, Zhang S, Jiang Z, Chen E, Huang K, Hu C, Zhang X, Wu J, Zhang Y, Gao H, Li L.

Aliment Pharmacol Ther. 2018 Aug 1. doi: 10.1111/apt.14927. [Epub ahead of print]

PMID:
30069888
19.

The abdominal wall hernia in cirrhotic patients: a historical challenge.

Salamone G, Licari L, Guercio G, Campanella S, Falco N, Scerrino G, Bonventre S, Geraci G, Cocorullo G, Gulotta G.

World J Emerg Surg. 2018 Jul 28;13:35. doi: 10.1186/s13017-018-0196-z. eCollection 2018.

20.

Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study.

Wang Y, Ma L, Yuan Z, Zheng J, Li W.

PLoS One. 2018 Jul 31;13(7):e0201525. doi: 10.1371/journal.pone.0201525. eCollection 2018.

Supplemental Content

Loading ...
Support Center